CCL2 and prostate neoplasm: More importantly, Loberg et al used a xenograft model of PC3 cells to demonstrate that CCL2 may enhance prostate tumour growth/metastasis in vivo by increasing the recruitment of TAMs and angiogenesis (Loberg et al, 2007).